199 related articles for article (PubMed ID: 34815099)
21. Paraptosis Inducer to Effectively Trigger Immunogenic Cell Death for Metastatic Tumor Immunotherapy with IDO Inhibition.
Zheng RR; Zhao LP; Huang CY; Cheng H; Yang N; Chen ZX; Cai H; Zhang W; Kong RJ; Li SY
ACS Nano; 2023 Jun; 17(11):9972-9986. PubMed ID: 37200049
[TBL] [Abstract][Full Text] [Related]
22. Cancer immunogenic cell death via photo-pyroptosis with light-sensitive Indoleamine 2,3-dioxygenase inhibitor conjugate.
Lu Y; Xu F; Wang Y; Shi C; Sha Y; He G; Yao Q; Shao K; Sun W; Du J; Fan J; Peng X
Biomaterials; 2021 Nov; 278():121167. PubMed ID: 34624752
[TBL] [Abstract][Full Text] [Related]
23. Tannins in Phyllanthus emblica L. improves cisplatin efficacy in lung cancer cells by boosting endoplasmic reticulum stress to trigger immunogenic cell death.
Hu Q; Wang S; Cheng R; Liu Y; Chang Z; Huang Y; Chen Y; Luo X; Zhou L; Wang B; Gao Y; Chen H; Liu R; Zhang L
Phytomedicine; 2024 Jan; 123():155219. PubMed ID: 38056150
[TBL] [Abstract][Full Text] [Related]
24. Smart biomimetic metal organic frameworks based on ROS-ferroptosis-glycolysis regulation for enhanced tumor chemo-immunotherapy.
Yang J; Ma S; Xu R; Wei Y; Zhang J; Zuo T; Wang Z; Deng H; Yang N; Shen Q
J Control Release; 2021 Jun; 334():21-33. PubMed ID: 33872626
[TBL] [Abstract][Full Text] [Related]
25. Nanoscale metal-organic framework delivers rapamycin to induce tissue immunogenic cell death and potentiates cancer immunotherapy.
Tian J; Wang J; Xu H; Zou B; Chen W; Liu Y; Chen J; Zhang R
Nanomedicine; 2023 Jun; 50():102678. PubMed ID: 37044194
[TBL] [Abstract][Full Text] [Related]
26. π-Extended Benzoporphyrin-Based Metal-Organic Framework for Inhibition of Tumor Metastasis.
Zeng JY; Zou MZ; Zhang M; Wang XS; Zeng X; Cong H; Zhang XZ
ACS Nano; 2018 May; 12(5):4630-4640. PubMed ID: 29584395
[TBL] [Abstract][Full Text] [Related]
27. Recent progress in stimuli-responsive nanosystems for inducing immunogenic cell death.
Banstola A; Poudel K; Kim JO; Jeong JH; Yook S
J Control Release; 2021 Sep; 337():505-520. PubMed ID: 34314800
[TBL] [Abstract][Full Text] [Related]
28. Engineering Dual-Responsive Prodrug-MOFs as Immunogenic Cell Death Initiator for Enhancing Cancer Immunotherapy.
Hu X; Li R; Liu J; Fang K; Dong C; Shi S
Adv Healthc Mater; 2024 Mar; 13(7):e2302333. PubMed ID: 38253350
[TBL] [Abstract][Full Text] [Related]
29. Synergistic Reinforcing of Immunogenic Cell Death and Transforming Tumor-Associated Macrophages Via a Multifunctional Cascade Bioreactor for Optimizing Cancer Immunotherapy.
Huang C; Lin B; Chen C; Wang H; Lin X; Liu J; Ren Q; Tao J; Zhao P; Xu Y
Adv Mater; 2022 Dec; 34(51):e2207593. PubMed ID: 36245299
[TBL] [Abstract][Full Text] [Related]
30. Semiconducting Polymer Nanoparticles with Surface-Mimicking Protein Secondary Structure as Lysosome-Targeting Chimaeras for Self-Synergistic Cancer Immunotherapy.
Qi J; Jia S; Kang X; Wu X; Hong Y; Shan K; Kong X; Wang Z; Ding D
Adv Mater; 2022 Aug; 34(31):e2203309. PubMed ID: 35704513
[TBL] [Abstract][Full Text] [Related]
31. Microwave-responsive gadolinium metal-organic frameworks nanosystem for MRI-guided cancer thermotherapy and synergistic immunotherapy.
Cui H; Zhao YY; Wu Q; You Y; Lan Z; Zou KL; Cheng GW; Chen H; Han YH; Chen Y; Qi XD; Meng XW; Ma LM; Yu GT
Bioact Mater; 2024 Mar; 33():532-544. PubMed ID: 38162511
[TBL] [Abstract][Full Text] [Related]
32. Multifunctional metal-organic framework-based nanoreactor for starvation/oxidation improved indoleamine 2,3-dioxygenase-blockade tumor immunotherapy.
Dai L; Yao M; Fu Z; Li X; Zheng X; Meng S; Yuan Z; Cai K; Yang H; Zhao Y
Nat Commun; 2022 May; 13(1):2688. PubMed ID: 35577812
[TBL] [Abstract][Full Text] [Related]
33. Laser/GSH-Activatable Oxaliplatin/Phthalocyanine-Based Coordination Polymer Nanoparticles Combining Chemophotodynamic Therapy to Improve Cancer Immunotherapy.
Huang Z; Chen Y; Zhang J; Li W; Shi M; Qiao M; Zhao X; Hu H; Chen D
ACS Appl Mater Interfaces; 2021 Aug; 13(33):39934-39948. PubMed ID: 34396771
[TBL] [Abstract][Full Text] [Related]
34. NIR-II light evokes DNA cross-linking for chemotherapy and immunogenic cell death.
Huang Y; Wei D; Wang B; Tang D; Cheng A; Xiao S; Yu Y; Huang W
Acta Biomater; 2023 Apr; 160():198-210. PubMed ID: 36792048
[TBL] [Abstract][Full Text] [Related]
35. Soft X-Ray Stimulated Lanthanide@MOF Nanoprobe for Amplifying Deep Tissue Synergistic Photodynamic and Antitumor Immunotherapy.
Zhao X; Li Y; Du L; Deng Z; Jiang M; Zeng S
Adv Healthc Mater; 2021 Nov; 10(21):e2101174. PubMed ID: 34585857
[TBL] [Abstract][Full Text] [Related]
36. Bimetallic metal-organic frameworks for tumor inhibition
Li A; Wang N; Song Y; Sun H; Cui J; Zhang G; Yu Q
Chem Commun (Camb); 2022 Feb; 58(14):2315-2318. PubMed ID: 35076033
[TBL] [Abstract][Full Text] [Related]
37. Immunogenicity-boosted cancer immunotherapy based on nanoscale metal-organic frameworks.
Li Q; Liu Y; Zhang Y; Jiang W
J Control Release; 2022 Jul; 347():183-198. PubMed ID: 35526612
[TBL] [Abstract][Full Text] [Related]
38. Multifunctional Lipid Bilayer Nanocarriers for Cancer Immunotherapy in Heterogeneous Tumor Microenvironments, Combining Immunogenic Cell Death Stimuli with Immune Modulatory Drugs.
Nel AE; Mei KC; Liao YP; Liu X
ACS Nano; 2022 Apr; 16(4):5184-5232. PubMed ID: 35348320
[TBL] [Abstract][Full Text] [Related]
39. Near-Infrared Light-Enhanced Generation of Hydroxyl Radical for Cancer Immunotherapy.
Zhang Q; Li Y; Jiang C; Sun W; Tao J; Lu L
Adv Healthc Mater; 2023 Nov; 12(28):e2301502. PubMed ID: 37409492
[TBL] [Abstract][Full Text] [Related]
40. Doxorubicin-Near infrared dye conjugate induces immunogenic cell death to enhance cancer immunotherapy.
Jin C; Wang Y; Li Y; Li J; Zhou S; Yu J; Wang Z; Yu Y; Zhang H; Wang D; He Z; Wang Y
Int J Pharm; 2021 Sep; 607():121027. PubMed ID: 34418473
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
